Recall Register

Device recall: Dial-A-Dose Insulin Delivery Device (Pen-Injector) cartridge holders Product Usage: The NovoPen Echo is a re-usable…

Class II FDA enforcement event 77704. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

A small number of batches may crack or break if exposed to certain chemicals, like certain cleaning agents.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Novo Nordisk Inc started this device recall on 5 Jul 2017. The firm address in the FDA record is in Plainsboro, NJ. FDA put the recall in Class II. FDA event 77704 has 1 product record. The first FDA enforcement report date is 13 Dec 2017. The record gives the status Terminated, with the termination date 9 Apr 2019.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide distribution

Recalling firm

Novo Nordisk Inc, Plainsboro, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 77704: product records
Recall numberProductQuantityClassStatusReport date
Z-0206-2018Dial-A-Dose Insulin Delivery Device (Pen-Injector) cartridge holders Product Usage: The NovoPen Echo is a re-usable pen injector for single patient use by diabetics for the self injection of a desired dose of insulin. The pen injector uses Penfill 3 mL cartridge of NovoLog, 100 units/mL (Ux100) [insulin aspart…16,557 unitsClass IITerminated13 Dec 2017

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2017
1,091
Share of these events in Class II
93%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
5

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 77704. https://recallregister.com/fda/ii/77704/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide distribution
What quantity of product is in FDA event 77704?
The FDA record gives this quantity: 16,557 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2017 have the same class?
93% of the 1,091 device events that started in 2017 are in Class II.